Prosthetic heart valve components

Through the artificial heart valve installed on the balloon and the multi-layer structure delivery catheter, the problems of inaccurate deployment and uneven expansion of traditional artificial heart valves are solved, and the accurate deployment and uniform expansion of the heart valves are achieved, reducing complications and Possibility of pacemaker use.

CN113473946BActive Publication Date: 2024-11-15MERIL LIFE SCI PVT LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN201980093035.5
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2019-08-13
Filing Date
2019-10-01
Publication Date
2024-11-15
Estimated Expiration
2039-10-01

Smart Images

  • Figure CN113473946B_ABST
    Figure CN113473946B_ABST
Patent Text Reader

Abstract

The present invention discloses an artificial heart valve assembly. The assembly includes an artificial heart valve (10). The valve (10) is mounted on a balloon (5) and is used to be deployed at a target location. The size of the valve (10) simulates the anatomical structure of a native heart valve. A delivery catheter (100) is used to deploy the artificial heart valve (10). The delivery catheter (100) includes a handle (11), an outer shaft (1) of a multilayer structure, and / or an inner shaft (3) including an inner shaft second end (3b). A support tube (7) is arranged on the inner shaft second end (3b) and includes one or more holes (7a) for allowing an inflation fluid to pass through, and the balloon (5) is arranged on the outer surface of the support tube. One or more stoppers (9) are arranged on the support tube (7) and are located in the balloon (5), and include a first part (C) and a second part (D).
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a medical device, and more particularly to an artificial heart valve assembly. Background Art

[0002] For many years, artificial heart valves have been used to treat heart valve diseases. In the natural course of aortic stenosis (a heart valve disease), varying degrees of heart obstruction may occur. Heart obstruction may be caused by calcium deposits near the native heart valve, such as at the valve ring of the native heart valve. The calcium deposits can gradually expand from the left ventricular outflow tract (LVOT) to the patient's arterio-ventricular conduction system. In order to overcome the above situation, the artificial heart valve is deployed in the patient's inner cavity at the target position (i.e., the patient's diseased heart valve) in a collapsed state (crimped condition). Traditional artificial heart valves block the left ventricular outflow tract (LVOT) and cannot be accurately fitted at the target position. In addition, during the radial collapse and radial expansion of traditional artificial heart valves, uneven distribution of radial forces will occur, which may lead to uneven expansion of the valve.

[0003] The conventional valve has a larger diameter, and therefore, uneven expansion of the valve may occur at the target location. The size of a conventional artificial heart valve may be different from the size of the native diseased valve, thereby affecting the wall near the ventricular septum and / or the papillary muscles near the native valve. Stress may be generated in the above situation due to muscle squeezing or contraction in these areas. The conventional valve may affect the vicinity of the diseased heart valve, namely the left ventricular outflow tract (LVOT) and the coronary artery ostium during deployment. The conventional valve excites the patient's cardiac conduction system and induces a new left bundle branch block (LBBB) during deployment. Due to the above-mentioned shortcomings of conventional artificial heart valves, sometimes after the deployment process, an external assist device such as a pacemaker (temporary / permanent type) is used to pace the heart and maintain its rhythm state.

[0004] Recently, transcatheter aortic valve implantation (TAVI) or replacement (TAVR) surgery is used to implant artificial heart valves for moderate-risk patients with severe aortic stenosis. TAVI surgery is performed to implant an artificial heart valve with the help of a delivery catheter, which may include a balloon, one or more stops, etc. In a TAVI surgery, the valve is mounted on a balloon located on a catheter and is in a collapsed position. The balloon is deployed from the femoral artery to the target location of the patient. The valve mounted on the balloon is inflated by providing an inflation fluid inside the balloon and expanding the valve at the target location.

[0005] However, in conventional delivery catheters, precise positioning of the artificial heart valve and the fitting of the valve face great challenges. The above situation may lead to serious complications during and after deployment. Severe complications may include valve embolism and coronary artery occlusion. In addition, the design and size of the conventional delivery catheter cannot maintain the design integrity and consistency of the artificial heart valve during deployment. The above deviations may be caused by a variety of reasons, such as the pushing resistance caused by the arterial condition, arterial size, and arterial occlusion; or the uneven fluid during the expansion of the artificial heart valve may cause conduction disorders and then LBB, which increases the chance of needing to use a temporary or permanent pacemaker device after the deployment process. The conventional delivery catheter may not be able to expand the artificial heart valve evenly, and may not be able to keep the outer contour size of the delivery catheter small. In addition, before the artificial heart valve is deployed to the target position, the conventional catheter may not maintain the linearity and center of gravity position of the artificial heart valve in the collapsed stage.

[0006] For example, patents EP2736457B1 and US9119716 disclose one or more stops including one or more grooves. The collapsed artificial heart valve loses its precise positioning due to these grooves, thereby affecting its linearity and thus affecting its center of gravity position. When a large thrust that affects the flexibility of the artificial heart valve is applied during deployment, the center of gravity position will also be affected. In addition, in the prior art, the inner shaft / inner tube passes through the stopper. When the stopper collapses, the groove is also collapsed, so that the gap between the inner shaft and the groove of the stopper becomes uneven. The above situation leads to uneven flow of fluid, thereby changing its fluid dynamics uniformity. Therefore, conventional stops cause uneven expansion of the catheter, which leads to blockage near the target position.

[0007] Therefore, there is a need for a delivery catheter designed to include a prosthetic heart valve that overcomes the deficiencies of conventional systems. Summary of the invention

[0008] The artificial heart valve assembly includes an artificial heart valve mounted on a balloon. The artificial heart valve is deployed in a target location, i.e., a diseased native heart valve. In an embodiment, the size of the artificial heart valve simulates the anatomical structure of the native heart valve.

[0009] The delivery catheter is used to deploy an artificial heart valve. The delivery catheter includes an outer shaft. The outer shaft also includes an outer shaft first end, an outer shaft second end and an inner cavity.

[0010] In an embodiment, the diameter of the first end of the outer shaft is greater than the diameter of the second end of the outer shaft.The outer shaft comprises one or more layers, namely an inner layer, a middle layer and an outer layer.

[0011] The inner shaft is arranged in the inner cavity of the outer shaft. The inner shaft comprises an inner shaft first end and an inner shaft second end. The inner shaft comprises one or more layers, namely a first layer, an intermediate layer and a second layer.

[0012] The support tube is arranged on the inner shaft second end of the inner shaft. The support tube includes one or more holes for allowing the inflation fluid to pass through. The balloon is arranged on the outer surface of the support tube.

[0013] A handle is provided at the end of the delivery catheter. One or more stoppers are arranged on the support tube and in the balloon. The one or more stoppers include a first part and a second part. BRIEF DESCRIPTION OF THE DRAWINGS

[0014] The above content of the invention and the following specific embodiments can be better understood in conjunction with the accompanying drawings. In order to illustrate the present disclosure, exemplary configurations of the present disclosure are shown in the accompanying drawings. However, the present disclosure is not limited to the specific methods and means disclosed herein. In addition, those skilled in the art will appreciate that the drawings are not drawn to scale.

[0015] Figure 1 An artificial heart valve according to an embodiment of the present invention is shown.

[0016] Figure 1a A delivery catheter according to an embodiment of the present invention is shown.

[0017] Figure 1b An outer shaft of a delivery catheter is shown in accordance with an embodiment of the present invention.

[0018] Figure 1c An inner shaft of a delivery catheter is shown in accordance with an embodiment of the present invention.

[0019] Figure 1d-Figure 1e One or more layers of an inner shaft according to an embodiment of the present invention are shown in FIG.

[0020] Figure 1f An enlarged view of components of a delivery catheter according to an embodiment of the present invention is shown.

[0021] Figure 1g and Figure 1h A perspective view of a balloon and one or more stops is shown in accordance with an embodiment of the present invention.

[0022] Figure 1i-1k Different implementations of one or more stops according to embodiments of the present invention are shown.

[0023] Figure 2 A flow chart of a deployment process of a prosthetic heart valve according to an embodiment of the present invention is illustrated. DETAILED DESCRIPTION

[0024] Before describing the present invention in detail, the definitions of certain words or phrases used throughout this patent document are defined here: the terms "include" and "comprising," and their derivatives, mean including but not limited to; the term "or" is inclusive, meaning and / or; the phrases "coupled with" and "associated with," and their derivatives may mean including, included within, interconnected with, containing, contained within, connected to or connected with, coupled to or coupled with, communicating with, cooperating with, alternating with, juxtaposed, proximate to, connected to or connected with, having the property of, etc. Definitions of certain words and phrases are provided throughout this patent document, and those of ordinary skill in the art will understand that in many, if not most, instances, such definitions apply to prior and future uses of such defined words and phrases.

[0025] Specific embodiments of the present disclosure are described below with reference to the accompanying drawings, however, it should be understood that the disclosed embodiments are only examples of the present disclosure, which can be embodied in various forms. Well-known functions or configurations are no longer described in detail here to avoid obscuring the content of the present disclosure due to unnecessary details. Therefore, the details of the specific structures and functions disclosed herein should not be interpreted as restrictive, but only as the basis for the claims and as a representative basis for teaching those skilled in the art to apply the present disclosure in various ways in virtually any appropriate specific structure.

[0026] It should be noted that in the present disclosure, the terms "valve", "heart valve", "artificial heart valve" and "prosthetic valve" are used interchangeably to refer to prosthetic heart valves, and therefore, all of the above phrases should have the same interpretation.

[0027] According to the present disclosure, an artificial heart valve and a delivery catheter (collectively referred to as an "artificial heart valve assembly") are disclosed. The artificial heart valve of the present invention is deployed at a target location (e.g., within a diseased native valve) with the help of a delivery catheter. The size of the artificial heart valve of the present invention (i.e., including a preset height, diameter, and surface area) is adjusted so that it simulates the autologous anatomical structure of the native heart valve. Therefore, the artificial heart valve does not destroy the autologous anatomical structure and function of the heart, which makes it unnecessary to have an external auxiliary device such as a pacemaker to maintain blood circulation in the patient's body after surgery. In an embodiment, the artificial heart valve of the present invention does not damage the left ventricular outflow tract (LVOT) located in the human heart. The artificial heart valve ensures that all small gaps close to the native heart valve are completely covered, which further helps to prevent paravalvular leakage.

[0028] The delivery catheter of the present invention makes the deployment of the artificial heart valve easy and accurate. The delivery catheter of the present invention may include one or more components. The one or more components may include a balloon, an outer shaft, an inner shaft, a support tube, one or more stops, etc. (described in detail below). In the process of delivering the valve from the patient's femoral artery entry point to the target position, one or more stops arranged in the delivery catheter ensure the accurate positioning of the artificial heart valve. The one or more stops of the present invention may have at least one hole for air movement and / or fluid to uniformly enter the balloon cavity.

[0029] The delivery catheter and artificial heart valve of the present invention do not affect, squeeze and / or interfere with the muscles and left ventricular outflow tract (LVOT) near the target location. In addition, the delivery catheter and artificial heart valve of the present invention do not block the coronary artery ostium, so an external temporary / permanent pacing device (pacemaker) is not required.

[0030] The following specifically refers to the accompanying drawings, Figure 1 An artificial heart valve 10 of the present invention is shown. The artificial heart valve 10 is deployed in the diseased native valve, that is, deployed at the target position. The artificial heart valve 10 can be a balloon-expandable valve, that is, the artificial heart valve 10 can be expanded by placing the valve on a balloon. In an embodiment, the artificial heart valve 10 is deployed to the target position in a collapsed state. Before implantation in the target position, the artificial heart valve 10 can be collapsed and set on the balloon on the delivery catheter. The collapsed contour size of the artificial heart valve 10 can be in the range of 6.8-8.0 mm, more preferably in the range of 7.0-7.6 mm. In an embodiment, the collapsed contour size of the artificial heart valve 10 is 7.3 mm.

[0031] The artificial heart valve 10 can be formed in preset sizes. The preset sizes of the artificial heart valve 10 can include, but are not limited to, surface area, diameter, and height. In an embodiment, the preset sizes of the artificial heart valve 10 are selected from gradually increasing sizes. Due to the above-mentioned gradually increasing sizes of the sizes (surface area, diameter, and height) of the artificial heart valve 10, the valve 10 can be effectively implanted in a 260mm 2 Up to 850mm 2 A range of sizes of annulus in native heart valves.

[0032] The surface area of ​​the artificial heart valve 10 gradually increases to 280 mm 2 -900mm 2 The surface area of ​​the artificial heart valve 10 gradually increases in the range of 30 mm 2 Up to 90mm 2 .

[0033] The gradually increasing size of the diameter of the artificial heart valve 10 may be 18 mm to 33.5 mm. The gradually increasing amplitude of the diameter of the artificial heart valve 10 may range from 1 mm to 2 mm.

[0034] The gradually increasing height of the artificial heart valve 10 may be 14 mm to 28 mm, more preferably 17-25 mm. The gradually increasing height of the artificial heart valve 10 may be 0.2 mm to 1 mm.

[0035] The selection of the gradually increasing sizes of the artificial heart valve 10 enables the artificial heart valve 10 to simulate the native anatomical structure of the diseased native valve. During the deployment of the valve 10, the artificial heart valve 10 of the appropriate size selected from the gradually increasing sizes does not affect the wall near the ventricular septum and / or the papillary muscles near the native valve. The artificial heart valve 10 of the appropriate size selected from the gradually increasing sizes does not generate any stress due to compression or contraction of the muscles in the ventricular septum area and / or the papillary muscles in the area near the native heart valve.

[0036] The artificial heart valve 10 of the present invention does not affect the position of the diseased native heart valve during deployment, and does not block the patient's left ventricular outflow tract (LVOT) and coronary artery ostium. The gradually increasing selectable sizes of the artificial heart valve 10 ensure that the valve will not excite the patient's cardiac conduction system and will not induce new left bundle branch block (LBBB) during deployment. Therefore, the artificial heart valve 10 eliminates the possibility of needing to use a temporary pacemaker and / or a permanent pacemaker (PPM) after its implantation. In an embodiment, clinical results after deployment of the artificial heart valve 10 show that the probability of requiring a temporary / permanent pacing device (pacemaker) after implantation of the artificial heart valve 10 of the present invention is less than 2%. In contrast, in conventional transcatheter aortic valve implantation systems, the probability of requiring a temporary / permanent pacemaker (pacemaker) after implantation is 12% to 15%.

[0037] A table of increasing selectable sizes of example prosthetic heart valves 10 is provided below:

[0038] Table 1

[0039] Serial number <![CDATA[Valve area (mm 2 )]]> Valve diameter (mm) Valve height (mm) 1 314 20 17.35 2 363 21.5 17.60 3 415 23 17.85 4 471 24.5 18.35 5 531 26 18.85 6 594 27.5 19.60 7 661 29 20.35 8 731 30.5 21.15 9 804 32 22.0 10 881 33.5 22.8

[0040] The artificial heart valve 10 may include, but is not limited to, a frame 10a, an outflow end 10b, an inflow end 10c, at least one leaflet 10d, an inner skirt 10e, and an outer skirt 10f.

[0041] The embodiments shown below demonstrate the advantages of using an artificial heart valve 10 that simulates a native heart valve.

[0042] Embodiment 1:

[0043] The patient's aortic annulus area was 545 mm 2 , requiring a transcatheter aortic valve implant. Based on the conventional sizes of available artificial heart valves, the doctor selected a heart valve with a surface area of ​​649mm 2 or 660mm 2 (Reference: Eur Heart J Cardiovasc Imaging. 2016 Sep; 17(9): 1054-1062), the diameter is 28 mm and the frame height is 20.35 mm. However, according to the size parameters of the artificial heart valve 10 of the present invention, the doctor can choose a closer available area of ​​594 mm 2 of artificial valves.

[0044] The excess area occupied by traditional artificial heart valves is 104mm 2 Up to 110mm 2 (19.08% to 20.18% above the required area). In contrast to the larger excess area occupied by conventional artificial heart valves, the artificial heart valve 10 of the present invention only exceeds the required area by 8.80%. Therefore, conventional valves are likely to obstruct the patient's entire native heart blood circulation. As a result, the wall near the ventricular septum and / or the papillary muscles near the diseased native heart valve may be disturbed, thereby affecting the ECG pulse.

[0045] Conventional valves may cause several other problems due to obstruction of blood flow, which may affect the function of adjacent valves, such as the mitral valve. In addition, since too much area of ​​the target location is covered, the chance of needing to implant a permanent and / or temporary pacemaker to regulate the normal function of the artificial heart valve increases. The above problems are minimized by implanting the artificial heart valve 10 of the present invention that simulates the autologous anatomical structure of the native heart valve. Therefore, the need to implant a permanent and / or temporary pacemaker is eliminated, thereby solving the above problems.

[0046] Figure 1a The delivery catheter 100 of the present invention is shown. The delivery catheter 100 is used to deploy an artificial heart valve (e.g., artificial heart valve 10) in a diseased native valve, i.e., at a target location. The delivery catheter 100 enables the artificial heart valve 10 to be easily and accurately deployed at the target location. The length of the delivery catheter 100 can be in the range of 1300-1700 mm, more preferably in the range of 1450-1550 mm. In an embodiment, the length of the delivery catheter 100 is 1500 mm.

[0047] The working or usable length of the delivery catheter 100 may be in the range of 1000-1400 mm, more preferably in the range of 1150-1250 mm. In an embodiment, the working or usable length of the delivery catheter 100 is 1200 mm.

[0048] The delivery catheter 100 includes a primary end (at Figure 1a A) and the secondary side (in Figure 1a The delivery catheter 100 further comprises one or more components. The one or more components may include, but are not limited to, an outer shaft / outer cavity / outer sheath 1, an inner shaft or inner cavity 3, a balloon 5, a support tube 7, one or more stoppers 9, a handle 11, and a soft tip 13.

[0049] The outer shaft 1 is used as the top layer of the delivery catheter 100. The outer shaft 1 may include an outer shaft first end 1a, an outer shaft second end 1b, a pull wire 1c (such as Figure 1b As shown) and hub 1d (as shown) Figure 1a ). In an embodiment, the outer shaft first end 1a is disposed near the proximal end of the balloon 5 of the delivery catheter 100, and the outer shaft second end 1b is disposed near the hub 11. The total length of the outer shaft 1 may be in the range of 1100-1600 mm, more preferably 1300-1400 mm. In an embodiment, the diameter of the outer shaft first end 1a of the outer shaft 1 may be different from the diameter of the outer shaft second end 1b.

[0050] The outer shaft first end 1a of the outer shaft 1 may have an outer diameter in the range of 2.5-6.5 mm, more preferably 4.0-5.0 mm, and an inner diameter in the range of 0.5-4.5 mm, more preferably 2.0-3.0 mm. The outer shaft second end 1b of the outer shaft 1 may have an outer diameter in the range of 1.5-5.5 mm, more preferably 3.0-4.0 mm, and an inner diameter in the range of 0.5-4.5 mm, more preferably 2.0-3.0 mm.

[0051] In an embodiment, the hub 1d is used to pass inflation fluid to inflate the balloon 5 .

[0052] The outer shaft 1 may be in the form of a hollow tube including an inner cavity (not shown). In an embodiment, the outer shaft 1 is used as a steerable mechanism having a pull-and-release mechanism, which pulls the wire 1c (in Figure 2 The steerable mechanism provides suitable flexion during advancement / implantation of the prosthetic heart valve 10 to the target location.

[0053] The outer shaft 1 may be a single-layer shaft or a multi-layer shaft. In an embodiment, the outer shaft 1 is a multi-layer shaft. The outer shaft 1 may include, but is not limited to, an inner layer, a middle layer, and an outer layer (not shown). The inner layer of the outer shaft 1 may be made of, but is not limited to, polytetrafluoroethylene (PTFE), nylon, or any other polymer.

[0054] The inner layer of the outer shaft 1 may be covered by the middle layer. In an embodiment, the middle layer of the outer shaft 1 is braided on the inner layer to provide flexibility at different locations during deployment. The middle layer of the outer shaft 1 may be braided using, but not limited to, flat or round wires of stainless steel, nitinol, or cobalt chromium. The braiding process is performed using a plurality of metal wires. The metal wires may be in the range of 4 to 32 wires, more preferably 8 to 24 wires.

[0055] In an embodiment, the outer shaft first end 1a of the outer shaft 1 is braided using any of the aforementioned wires. The length of the outer shaft first end 1a of the outer shaft 1 can be in the range of 950-1300 mm, more preferably in the range of 1100-1150 mm. Braiding is performed at the outer shaft first end 1a of the outer shaft 1 to provide sufficient strength, flexibility and anti-kink properties for the outer shaft 1. In addition, different levels of polymers are welded together at specific locations in the outer shaft 1 to facilitate turning the outer shaft 1.

[0056] In the embodiment, the outer shaft second end 1b of the outer shaft 1 is not braided. The length of the outer shaft second end 1b of the outer shaft 1 may be in the range of 5-200 mm, more preferably in the range of 50-120 mm.

[0057] In an embodiment, the pull wire 1c used in the steerable mechanism is woven using multiple metal wires used in the middle layer of the outer shaft 1. The pull wire 1c can be a monofilament wire or a multifilament wire. In an embodiment, the pull wire 1c is a monofilament wire. The pull wire 1c can also include a pull ring (not shown), which helps to provide a steerable mechanism to the outer shaft 1. The pull wire 1c connected to the pull ring is arranged on the outer shaft first end 1a of the outer shaft 1. The length of the pull wire 1c can be in the range of 1000-1600mm, more preferably in the range of 1200-1400mm.

[0058] The middle layer of the outer shaft 1 can be further covered by the outer layer of the outer shaft 1 so as to maintain the flexibility of the outer shaft 1 at different positions during deployment. The outer layer of the outer shaft 1 can be made of the following polymer materials: nylon, polytetrafluoroethylene (PTFE), modified nylon (pebax), polyamide, polyetheretherketone (PEEK), silicone and other derivatives, etc., but not limited to this. In an embodiment, the outer shaft 1 is made of modified nylon (pebax) and polyamide resin. The product grades of modified nylon (pebax) used to form the outer shaft 1 include modified nylon (pebax) 2533, modified nylon (pebax) 3533, modified nylon (pebax) 4033, modified nylon (pebax) 5533, modified nylon (pebax) 6333, modified nylon (pebax) 7033, modified nylon (pebax) 7233 and modified nylon (pebax) 7433. The outer shaft 1 is made of modified nylon (pebax) because the material is biocompatible. Modified nylon (pebax) has efficient mechanical properties, such as light weight, high flexibility, excellent physical properties and chemical resistance. Other materials with similar properties can also be used to form the outer layer of the outer shaft 1.

[0059] The inner shaft 3 is arranged in the inner cavity of the outer shaft 1 (such as Figure 1c 1). The inner shaft 3 may include an inner shaft first end 3a and an inner shaft second end 3b. In an embodiment, the inner shaft first end 3a is disposed near the primary end A of the delivery catheter 100, and the inner shaft second end 3b is disposed near the secondary end B of the delivery catheter 100. The inner shaft 3 is disposed in the inner cavity of the outer shaft 1 to extend from the first end A of the delivery catheter to the outer shaft second end 1b of the outer shaft 1. The inner shaft 3 passes through the inner cavity of the support tube 7 from the outer shaft first end 1a of the outer shaft 1 into the interior of the balloon 5 and extends to the second end B of the delivery catheter 100, at which the inner shaft second end 3b of the inner shaft 3 is disposed. The inner shaft 3 also includes an inner cavity (not shown). The inner cavity of the inner shaft 3 is used as a channel for a guidewire. The guidewire may be any guidewire known in the art.

[0060] The inner shaft 3 may be a single-layer shaft or a multi-layer shaft. In an embodiment, the inner shaft 3 is a multi-layer shaft. The inner shaft 3 may include but is not limited to a first layer, an intermediate layer, and a second layer (such as Figure 1d ). The first layer of the inner shaft 3 serves as a base layer of the inner shaft 3. The first layer of the inner shaft 3 may be made of the following materials: nylon, PTFE, modified nylon (pebax), polyimide, PEEK, silicone, etc., but is not limited thereto. In an embodiment, the first layer of the inner shaft 3 is made of polyimide, which provides a smooth surface to reduce friction when the guide wire moves.

[0061] The first layer of the inner shaft 3 is covered by the middle layer. In an embodiment, the middle layer of the inner shaft 3 has a woven structure (such as Figure 1eThe intermediate layer may be braided using round or flat metal wires. The round or flat metal wires may be made of, but not limited to, nitinol, cobalt chromium or stainless steel (SS) materials. In an embodiment, braiding is done with stainless steel wires. Braiding may be performed at a braiding angle of 60° to 120°, more preferably 80° to 100°.

[0062] The middle layer of the inner shaft 3 is covered by the second layer. In an embodiment, the second layer of the inner shaft 3 can serve as a covering layer of the inner shaft 3. The second layer of the inner shaft 3 can be made of the following materials: nylon, polytetrafluoroethylene (PTFE), polyimide, modified nylon (pebax), polyetheretherketone (PEEK), silicone and other derivatives, but not limited thereto. In an embodiment, the second layer of the inner shaft 3 is made of polyimide, which provides flexibility to the first layer of the inner shaft 3.

[0063] The inner shaft 3 may have a length of 1200-1800 mm, more preferably in the range of 1400-1600 mm. The inner shaft 3 may have an outer diameter in the range of 0.1-2.5 mm, more preferably in the range of 1.0-1.5 mm, and an inner diameter of 0.1-2.0 mm, more preferably in the range of 0.6-1.2 mm.

[0064] The balloon 5 is disposed toward the secondary end B of the delivery catheter 100. The balloon 5 includes a proximal end 5a, a distal end 5b, and a middle portion 5c (eg, Figure 1f ). In an embodiment, the proximal end 5a of the balloon 5 is connected to the outer shaft second end 1b of the outer shaft 1, and the distal end 5b of the balloon 5 is connected to the soft tip 13. The balloon 5 can be a single-layer component or a multi-layer component. In an embodiment, the balloon 5 is a single-layer component. In an embodiment, the middle part 5c of the balloon 5 is a hollow cylindrical shape. The proximal end 5a and the distal end 5b of the balloon 5 are conical.

[0065] The balloon 5 may be made of a variety of polymer materials including but not limited to nylon, modified nylon (pebax), polyethylene terephthalate (PET), polyamide, polyurethane, polyvinyl chloride, polyethylene, etc. In an embodiment, the balloon 5 is made of polyamide resin, but is not limited thereto.

[0066] The balloon 5 can be used to expand the artificial heart valve 10. In an embodiment, the artificial heart valve 10 is placed on the balloon 5. Therefore, when the balloon 5 expands, the artificial heart valve 10 also expands. In an embodiment, the balloon 5 is deployed in a collapsed state together with the artificial heart valve 10, and the balloon 5 and the artificial heart valve 10 are expanded once they reach the target position. In an embodiment, once the balloon 5 and the artificial heart valve 10 are fully expanded at the target position, the balloon 5 is withdrawn from the target position. The expansion of the balloon 5 together with the artificial heart valve 10 is carried out under the action of an expansion fluid. The expansion fluid may include, but is not limited to, a physiological saline solution. In an embodiment, the amount of expansion fluid required to fill the balloon 5 depends on the diameter of the balloon 5. The volume of the expansion fluid filled in the balloon 5 can be in the range of 5 to 100 ml, more preferably 15 to 60 ml.

[0067] The proximal and distal ends (5a and 5b) of the balloon 5 may include a lumen including a support tube 7 (described below).

[0068] In an embodiment, the balloon 5 includes at least two markers (not shown). The at least two markers can be made of a radiopaque material. The at least two markers help to position the artificial heart valve 10 in the aortic orifice lumen of the patient during the deployment process. The at least two markers are set within the working length of the balloon 5 (i.e., within the balloon 5 component). The working length of the balloon 5 can be in the range of 15-45mm, more preferably 25-45mm. In an embodiment, the working length of the balloon 5 is 35mm.

[0069] The outer diameter of the balloon 5 ranges from 16 to 36 mm, more preferably from 20 to 32 mm. In an embodiment, the outer diameter of the balloon 5 depends on the diameter of the artificial heart valve 10 so as to provide uniform expansion for the artificial heart valve 10.

[0070] The support tube 7 is arranged inside the inner cavity of the balloon 5 (such as Figure 1f The support tube 7 is a spherical support tube 7 having a proximal end 3b and a distal end 5b. The support tube 7 includes a lumen that supports the balloon 5 during expansion and contraction of the artificial heart valve 10. The lumen also helps to deliver an inflation fluid into the balloon 5 to expand the balloon 5, which in turn expands the artificial heart valve 10. The support tube 7 also includes a distal opening and a proximal opening (not shown). In an embodiment, the proximal opening is disposed near the proximal end 5a of the balloon 5 and the distal opening is disposed near the distal end 5b of the balloon 5.

[0071] The support tube 7 may include one or more holes 7a near the distal opening and / or the proximal opening. In an embodiment, the one or more holes are disposed near the proximal opening of the support tube 7. The distal opening and the one or more holes 7a disposed at the proximal opening of the support tube 7 serve as passages for the inflation fluid. In an embodiment, the inflation fluid enters the balloon 5 via the support tube 7. The distal opening and the one or more holes 7a disposed at the proximal opening of the support tube 7 ensure uniform inflation of the balloon 5, thereby ensuring uniform inflation of the artificial heart valve 10 when deployed at the target position.

[0072] The support tube 7 can be made of any polymer material. The polymer material can include, but is not limited to, nylon, polytetrafluoroethylene (PTFE), modified nylon (pebax), polyetheretherketone (PEEK), silicone and other derivatives. In an embodiment, the support tube 7 is made of polyamide. The length of the support tube 7 can be 40-100mm, more preferably in the range of 50-80mm. In an embodiment, the length of the support tube 7 together with one or more stoppers 9 is 65-80mm. The length of the support tube depends on the length of the balloon 5.

[0073] The support tube 7 also includes an outer diameter and an inner diameter. The outer diameter of the support tube 7 can be in the range of 0.5-4.5 mm, more preferably in the range of 2.0-3.0 mm. The inner diameter of the support tube 7 can be in the range of 0.1-4.0 mm, more preferably in the range of 1.5-2.5 mm.

[0074] One or more stoppers 9 are disposed at the proximal and distal ends (5a and 5b) of the balloon 5 and mounted on the outer surface (not shown) of the support tube 7. Figure 1f , Figure 1g and Figure 1h As shown, the one or more stoppers 9 include two stoppers (a proximal stopper 9a and a distal stopper 9b). The proximal stopper 9a is disposed at the proximal end 5a of the balloon 5. The distal stopper 9b is disposed at the distal end 5b of the balloon 5. When the proximal stopper 9a and the distal stopper 9b are mounted on the outer surface of the support tube 7, the distance between the two can be in the range of 15-50 mm, more preferably 18-40 mm.

[0075] The one or more stoppers 9 may be made of the following materials: medical grade polyurethane, silicone, polyimide, nylon, polytetrafluoroethylene (PTFE) and other polymer combinations, but not limited thereto. In an embodiment, the one or more stoppers 9 are made of polyurethane.

[0076] One or more stoppers 9 may include a first portion (at Figures 1i-1k C) and the second part (in Figures 1i-1kThe first part C and the second part D may have a preset thickness. The thickness of the first part C may be 0.10-1.20 mm, more preferably in the range of 0.45-0.65 mm, and the thickness of the second part D may be 0.05-3.5 mm, more preferably in the range of 1.0-2.0 mm. The thickness of the one or more stoppers 9 plays an important role in maintaining the required flexibility thereof. One or more stoppers 9 having a thicker thickness have less flexibility, but if the thickness is too thin, the breakage rate of the one or more stoppers 9 becomes high. Therefore, the one or more stoppers 9 of the present invention have a thickness of an intermediate value to overcome the above-mentioned problems.

[0077] like Figure 1i-1k As shown, the first portion C of the one or more stoppers 9 is conical and includes a lower end (at Figure 1i-1k C1) and the upper end (in Figure 1i-1k Marked as C2).

[0078] In an embodiment, the lower end C1 includes Figure 1i-1k The lower end C1 may be permanently and / or temporarily attached to the second portion D. In an embodiment, the lower end C1 includes a preset inner diameter and outer diameter. The outer diameter of the lower end C1 may be in the range of 1.5 mm to 6.5 mm, more preferably in the range of 3.5 mm to 4.5 mm. The inner diameter of the lower end C1 may be in the range of 0.5 mm to 5.0 mm, more preferably in the range of 2.0 mm to 3.5 mm.

[0079] In an embodiment, the upper end C2 is a free end. The upper end C2 may have a Figure 1i-1k In the embodiment, as shown in the various shapes Figure 1i As shown, the upper end C2 has an extendable portion (at Figure 1i The rim-shaped structure of the prosthetic heart valve 10 is a rim-shaped structure (marked as 'E' in the figure). The rim-shaped structure is efficient when high thrust is required during deployment due to stenosis of the patient's arteries. The rim-shaped structure also helps to maintain the collapsed position of the prosthetic heart valve 10 during the deployment process and guide the delivery catheter 100 through the introducer sheath (not shown). The structure also helps in uniform expansion of the collapsed prosthetic heart valve 10. Figure 1g A perspective view of one or more stoppers 9 having a rim-shaped structure with an extendable portion E arranged inside the balloon 5 is shown.

[0080] In another embodiment, as follows Figure 1jAs shown, the upper end C2 is a crown-shaped structure with alternating peaks and valleys. The crown-shaped structure provides greater flexibility during the expansion / contraction of the balloon 5. The crown-shaped structure also allows additional inflation fluid to enter the interior of the balloon 5 to expand / contract the balloon 5. Figure 1h A perspective view of one or more stops 9 disposed within the balloon 5 having a crown-shaped structure with alternating peaks and valleys is shown.

[0081] In yet another embodiment, as follows Figure 1k As shown, the upper end C2 includes a uniform periphery. The uniform periphery of the second end C2 helps to reduce the collapsed profile size of the artificial heart valve 10. The uniform periphery also reduces the overall diameter of the collapsed artificial heart valve 10 for ease of advancement during deployment. Figure 1f A perspective view of one or more stops 9 having a uniform outer circumference disposed within a balloon 5 is shown.

[0082] In an embodiment, the upper end C2 includes a preset inner diameter and outer diameter. The outer diameter of the upper end C2 may be in the range of 4.5 mm to 9.5 mm, more preferably in the range of 6.5 mm to 7.5 mm. The inner diameter of the upper end "C2" may be in the range of 1.5 mm to 6.5 mm, more preferably in the range of 3.5 mm to 4.5 mm.

[0083] In an embodiment, Figure 1i-1k As shown, the second portion D of the one or more stoppers 9 is cylindrical. The preset diameter of the second portion D can be in the range of 3.5 mm to 4.5 mm. The preset length of the second portion D can be in the range of 3.3 mm to 5.0 mm. The second portion D can include at least one hole (in Figure 1i-1k In the embodiment, the at least one hole D1 of the second portion D is used to connect one or more stoppers 9 to the support tube 7. The at least one hole D1 of the second portion D can be any shape known in the art. In an embodiment, the at least one hole D1 is circular. The diameter of the at least one hole D1 can be in the range of 0.1-2.0 mm, more preferably in the range of 0.5-1.5 mm.

[0084] In an embodiment, when the first portion C and the second portion D are connected together, a funnel shape (eg, Figure 1i , Figure 1j and Figure 1k shown).

[0085] One or more stops 9 are used to prevent the artificial heart valve 10 from shifting during delivery from the femoral artery access to the target location. In an embodiment, the artificial heart valve 10 is placed between the one or more stops 9. The length between the one or more stops 9 can be in the range of 8-20 mm, more preferably in the range of 12-16 mm. In an embodiment, the length between the one or more stops 9 is 16 mm.

[0086] The handle 11 is disposed near the proximal end A of the delivery catheter 100. The handle 11 may include, but is not limited to, a threaded spindle (not shown). The handle 11 is used to guide the push-pull mechanism or the steerable mechanism of the outer shaft 1. The length of the handle 11 may be in the range of 80-220 mm, more preferably in the range of 120-180 mm.

[0087] In an embodiment, the handle 11 is provided in the form of a housing with a threaded spindle disposed within the housing. The length of the housing of the handle 11 may be in the range of 60-160 mm, more preferably 100-120 mm.

[0088] The length of the threaded spindle of the handle 11 may be in the range of 50-100 mm, more preferably 60-80 mm.

[0089] The soft tip 13 is disposed at the secondary end B of the delivery catheter 100 and is connected to the distal end 5b of the balloon 5 (eg, Figure 1c ). A soft tip 13 is provided to facilitate advancement of the delivery catheter 100 during the deployment process. The soft tip 13 also facilitates guiding the delivery catheter 100 through curved blood vessels without puncturing or damaging the blood vessels, because the soft tip 13 bends during deployment to pass through the patient's vascular system.

[0090] The soft tip 13 may be made of the following materials: modified nylon (pebax), polymer, polyurethane, etc., but is not limited thereto. In an embodiment, the soft tip 13 is made of a low hardness polymer. In an embodiment, the soft tip 13 is conical. The outer diameter of the soft tip 13 may be in the range of 4-8 mm. The total length of the soft tip 13 may be in the range of 10-20 mm.

[0091] Optionally / additionally, the delivery catheter 100 may include an introducer sheath (not shown). The introducer sheath is used to deploy the collapsed prosthetic heart valve 10 to a target location.

[0092] Figure 2 The diagram shows a deployment process of the prosthetic heart valve 10 being deployed to a target location with the aid of a delivery catheter 100. The deployment process starts at step 201.

[0093] In step 201, the delivery catheter 100 is pushed into the patient's vascular system. The steps are performed to deploy the artificial heart valve 10 to the patient's diseased native valve (i.e., the target location). In an embodiment, the artificial heart valve 10 is deployed in a collapsed state together with the balloon 5. The above steps are performed by utilizing the steerable mechanism with a wire pulling and releasing mechanism of the outer shaft 1.

[0094] When the delivery catheter enters the patient's vascular system, the soft tip 13 of the delivery catheter 100 serves to guide the delivery catheter 100 forward. After entering the patient's vascular system, the delivery catheter 100 passes through multiple bends in the patient's artery. In order to smoothly pass through the bends, the pull wire 1c connected to the retractor (not shown) is pulled in the direction of the aortic arch. The retractor is combined with the threaded spindle of the handle 11 so that the secondary end B of the delivery catheter 100 is bent. The threaded spindle rotates (for example, clockwise), thereby moving the retractor toward the end of the handle 11. The movement stretches the pull ring of the pull wire, causing the flexible portion of the outer shaft 1 to bend accordingly. The above steps are performed until the delivery catheter 100 reaches the patient's native valve (i.e., the target position).

[0095] At step 203 , the collapsed balloon 5 (which is disposed on the delivery catheter 100 ) is inflated to attach the collapsed artificial heart valve 10 to the native valve ring. After entering the target position, the inflation fluid enters the balloon 5 through the support tube 7 and one or more stoppers 9 .

[0096] First, the inflation fluid inflates the proximal end 5a and the distal end 5b of the balloon 5. The inflation of the proximal end 5a and the distal end 5b of the balloon 5 helps maintain the position of the collapsed artificial heart valve 10. The above-mentioned inflation also helps maintain the inflation height of the collapsed artificial heart valve 10.

[0097] The inflation fluid then enters the middle portion 5c of the balloon 5. As the inflation fluid gradually accumulates inside the balloon 5, the balloon 5 gradually expands in its peripheral area without interfering with the collapsed profile of the artificial heart valve 10. This allows the artificial heart valve 10 to expand uniformly at the target location.

[0098] After the artificial heart valve 10 is expanded, the inflation fluid is withdrawn through the hub 1d of the outer shaft 1, causing the balloon 5 to deflate.

[0099] At step 205, the delivery catheter 100 is withdrawn from the patient's vasculature. The withdrawal step is performed with the aid of the steerable mechanism of the outer shaft 1 with the wire-pull mechanism (as described in step 201) without disturbing the blood vessels within the patient's vasculature.

[0100] The scope of the present invention is limited only by the claims of the attached patent application. More generally, it should be readily understood by those skilled in the art that all parameters, dimensions, materials and configurations described herein are exemplary, and actual parameters, dimensions, materials and / or configurations will depend on the specific application scenarios in which the technical teachings of the present invention are used.

Claims

1. An artificial heart valve assembly, comprising: a. an artificial heart valve (10) mounted on a balloon (5) for deployment at a target location, wherein the artificial heart valve (10) has a preset diameter and a preset height to simulate the anatomical structure of a native heart valve, the preset diameter being selected from a gradually increasing diameter from 18 mm to 33.5 mm, and the preset height being selected from a gradually increasing height from 14 mm to 28 mm, so that a pacemaker is not required after the artificial heart valve is implanted; b. A delivery catheter (100) for deploying the artificial heart valve (10), wherein the delivery catheter (100) comprises: i. an outer shaft (1), comprising an outer shaft first end (1a), an outer shaft second end (1b) and an inner cavity, wherein the diameter of the outer shaft first end (1a) is greater than the diameter of the outer shaft second end (1b), wherein the outer shaft (1) has one or more layers; ii. an inner shaft (3) disposed in the inner cavity of the outer shaft (1) and comprising an inner shaft first end (3a) and an inner shaft second end (3b), wherein the inner shaft (3) has one or more layers; iii. a support tube (7) disposed on the inner shaft second end (3b) of the inner shaft (3) and comprising an inner cavity, the inner cavity of the support tube (7) supporting the balloon (5), wherein the support tube (7) comprises one or more holes (7a) for allowing an inflation fluid to pass through the inner cavity of the support tube (7) to enter the balloon (5); iv. a handle (11) disposed at the end of the delivery catheter (100); and v. One or more stoppers (9), which are arranged on the support tube (7) and located inside the balloon (5), and the one or more stoppers (9) include a first part (C) and a second part (D).

2. The artificial heart valve assembly according to claim 1, wherein: The outer shaft (1) has at least three layers, including an inner layer, a middle layer and an outer layer, wherein the middle layer is woven on the inner layer.

3. The artificial heart valve assembly according to claim 1, wherein: The outer shaft (1) comprises a hub (1d) for passing the inflation fluid to inflate the balloon (5).

4. The artificial heart valve assembly according to claim 1, wherein: The outer shaft (1) comprises a steerable mechanism for deploying the prosthetic heart valve (10).

5. The artificial heart valve assembly according to claim 1, wherein: The inner shaft (3) has at least three layers, including a first layer, a middle layer and a second layer, wherein the middle layer has a woven structure.

6. The artificial heart valve assembly according to claim 1, wherein: The first portion (C) has a conical shape and includes a lower end (C1) and an upper end (C2).

7. The artificial heart valve assembly according to claim 6, wherein: The lower end (C1) comprises a uniform outer circumference and the upper end (C2) has a rim-shaped structure including an extendable portion (E).

8. The artificial heart valve assembly according to claim 6, wherein: The lower end (C1) comprises a uniform outer circumference and the upper end (C2) has a crown-shaped structure comprising alternating peaks and valleys.

9. The artificial heart valve assembly according to claim 1, wherein: The second portion (D) has a cylindrical shape and comprises at least one hole (D1) for connecting the one or more stoppers (9) to the support tube (7).